| Modulation of gene expression and tumor cell growth by redox modification of STAT3 L Li, S Cheung, EL Evans, PE Shaw Cancer research 70 (20), 8222-8232, 2010 | 134 | 2010 |
| BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers Z Tang, X Yuan, R Du, SH Cheung, G Zhang, J Wei, Y Zhao, Y Feng, ... Molecular cancer therapeutics 14 (10), 2187-2197, 2015 | 68 | 2015 |
| Characterization of TAT-mediated transport of detachable kinase substrates JS Soughayer, Y Wang, H Li, SH Cheung, FM Rossi, EJ Stanbridge, ... Biochemistry 43 (26), 8528-8540, 2004 | 50 | 2004 |
| Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcription C Luo, E Pook, B Tang, W Zhang, S Li, K Leineweber, SH Cheung, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1863 (9 …, 2017 | 33 | 2017 |
| RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K‐RAS mutant tumors X Yuan, Z Tang, R Du, Z Yao, SH Cheung, X Zhang, J Wei, Y Zhao, Y Du, ... Molecular Oncology 14 (8), 1833-1849, 2020 | 30 | 2020 |
| Discovery and characterization of the potent and highly selective 1, 7-naphthyridine-based inhibitors BAY-091 and BAY-297 of the kinase PIP4K2A L Wortmann, N Bräuer, SJ Holton, H Irlbacher, J Weiske, C Lechner, ... Journal of Medicinal Chemistry 64 (21), 15883-15911, 2021 | 15 | 2021 |
| ADTRP regulates TFPI expression via transcription factor POU1F1 involved in coronary artery disease C Luo, E Pook, F Wang, SR Archacki, B Tang, W Zhang, JS Hu, J Yang, ... Gene 753, 144805, 2020 | 11 | 2020 |
| Anomalous behaviour of the STAT3 binding site in the human c-myc P2 promoter S Vougier, SH Cheung, L Li, G Hodgson, PE Shaw Biochemical and biophysical research communications 364 (3), 627-632, 2007 | 9 | 2007 |
| Aspirin inhibits prostaglandins to prevents colon tumor formation via down-regulating Wnt production Y Feng, L Tao, G Wang, Z Li, M Yang, W He, X Zhong, Y Zhang, J Yang, ... European Journal of Pharmacology 906, 174173, 2021 | 8 | 2021 |
| RAF dimer inhibitor lifirafenib enhances the antitumor activity of MEK inhibitor mirdametinib in RAS mutant tumors X Yuan, X Zhang, R Du, SH Cheung, M Wei, C Zhou, L Wang, T Shearer, ... Cancer Research 80 (16_Supplement), 6415-6415, 2020 | 3 | 2020 |
| BGB-283 effectively enhances MEK inhibitor induced tumor suppression in RAS mutant cancers X Yuan, Z Tang, R Du, SH Cheung, J Wei, Y Zhao, Y Du, R Hao, X Hu, ... Cancer Research 75 (15_Supplement), 669-669, 2015 | 2 | 2015 |
| Androgen Inhibits Key Atherosclerotic Processes by Directly Activating ADTRP Transcription Q Chen, C Luo, K Leineweber, B Tang, W Zhang, S Li, E Pook, ... Arteriosclerosis, Thrombosis, and Vascular Biology 37 (suppl_1), A409-A409, 2017 | | 2017 |
| 136 Identification and Characterization of BRAF Inhibitors That Inhibit Vemurafenib-Resistant P61BRAFV600E SH Cheung, R Du, Y Zhao, R Hao, GL Zhang, SH Wang, M Wei, CY Zhou, ... European Journal of Cancer, 42, 2012 | | 2012 |
| Regulation of Stat3 by reactive oxygen species SH Cheung, L Li, S Vougier, PE Shaw Cancer Research 68 (9_Supplement), 867-867, 2008 | | 2008 |
